Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells

Cellular & Molecular Immunology volume 7, pages 440–446 (2010)Cite this article

Abstract

A dendritic cell (DC) vaccine strategy has been developed as a new cancer immunotherapy, but the goal of complete tumor eradication has not yet been achieved. We have previously shown that baculoviruses potently infect DCs and induce antitumor immunity against hepatomas in a mouse model. Baculovirus-infected, bone marrow-derived DCs (BMDCs) display increased surface expression of costimulatory molecules, such as CD80, CD86 and major histocompatibility complex (MHC) classes I and II, and secrete interferons and other proinflammatory cytokines. In this study, we evaluated the induction of antitumor immunity in mice by baculovirus-infected BMDCs against lung cancer and melanoma. After treatment with baculovirus-infected BMDCs, murine lung tumors caused by Lewis lung carcinoma (LLC) cells were significantly reduced in size, and the survival of the mice was improved. In addition, experiments using a melanoma mouse model showed that baculovirus-infected BMDCs inhibited tumor growth and improved survival compared with controls. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine levels remained normal in baculovirus-infected BMDC-treated mice. Our findings show that baculovirus-infected DCs induce antitumor immunity and pave the way for the use of this technique as an effective tool for DC immunotherapy against malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Aarntzen EH, Figdor CG, Adema GJ, Punt CJ, de Vries IJ . Dendritic cell vaccination and immune monitoring. Cancer Immunol Immunother 2008; 57: 1559–1568.

    Article  CAS  Google Scholar 

  2. Huser A, Hofmann C . Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications. Am J Pharmacogenomics 2003; 3: 53–63.

    Article  CAS  Google Scholar 

  3. Stewart LM, Hirst M, López-Ferber M, Merryweather AT, Cayley PJ, Possee RD . Construction of an improved baculovirus insecticide containing an insect-specific toxin gene. Nature 1991; 352: 85–88.

    Article  CAS  Google Scholar 

  4. Jennifer SC, Mark LH, Trevor W, Rosemary SH, David G, Bernadette MG et al. Field trial of a genetically improved baculovirus insecticide. Nature 1994; 370: 138–140.

    Article  Google Scholar 

  5. Berger I, Fitzgerald DJ, Richmond TJ . Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 2004; 22: 1583–1587.

    Article  CAS  Google Scholar 

  6. Matsuura Y, Possee RD, Overton HA, Bishop DH . Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol 1987; 68: 1233–1250.

    Article  CAS  Google Scholar 

  7. Song SU, Boyce FM . Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin). Exp Mol Med 2001; 33: 46–53.

    Article  CAS  Google Scholar 

  8. Yla-Herttuala S, Alitalo K . Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694–701.

    Article  Google Scholar 

  9. Tjia ST, zu Altenschildesche GM, Doerfler W . Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 1983; 125: 107–117.

    Article  CAS  Google Scholar 

  10. Condreay JP, Witherspoon SM, Clay WC, Kost TA . Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127–132.

    Article  CAS  Google Scholar 

  11. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H . Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003; 171: 1133–1139.

    Article  CAS  Google Scholar 

  12. Liqun L, Yu L, Kwang J . Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 2007; 358: 404–409.

    Article  Google Scholar 

  13. Yang DG, Chung YC, Lai YK, Lai CW, Liu HJ, Hu YC . Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007; 15: 989–996.

    Article  CAS  Google Scholar 

  14. Strauss R, Hüser A, Ni S, Tuve S, Kiviat N, Sow PS et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007; 15: 193–202.

    Article  CAS  Google Scholar 

  15. Fan H, Pan Y, Fang L, Wang D, Wang S, Jiang Y et al. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 2008; 150: 21–26.

    Article  CAS  Google Scholar 

  16. Abe T, Hemmi H, Moriishi K, Tamura S, Takaku H, Akira S et al. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005; 79: 2847–2858.

    Article  CAS  Google Scholar 

  17. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, Uematsu S et al. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type specific manner. J Virol 2009; 83: 7629–7640.

    Article  CAS  Google Scholar 

  18. Schütz A, Scheller N, Breinig T, Meyerhans A . The Autographa californica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine 2006; 24: 7190–7196.

    Article  Google Scholar 

  19. Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C . Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 2007; 178: 2361–2369.

    Article  CAS  Google Scholar 

  20. Jordan KR, McMahan RH, Oh JZ, Pipeling MR, Pardoll DM, Kedl RM et al. Baculovirus-infected insect cells expressing peptide–MHC complexes elicit protective antitumor immunity. J Immunol 2008; 180: 188–197.

    Article  CAS  Google Scholar 

  21. Kitajima M, Abe T, Miyano-Kurosaki N, Taniguchi M, Nakayama T, Takaku H . Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther 2008; 16: 261–268.

    Article  CAS  Google Scholar 

  22. Suzuki T, Chang MO, Kitajima M, Takaku H . Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol 2010; 262: 35–43.

    Article  CAS  Google Scholar 

  23. Inaba K, Inaba M, Romani N, Aya H Deguchi M, Ikehara S et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693–1702.

    Article  CAS  Google Scholar 

  24. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740–745.

    Article  CAS  Google Scholar 

  25. Yoneyama Y, Ueda Y, Akutsu Y, Matsunaga A, Shimada H, Kato T et al. Development of immunostimulatory virotherapy using non-transmissible sendai virus-activated dendritic cells Biochem Biophys Res Commun 2007; 355: 129–135.

    Article  CAS  Google Scholar 

  26. Boudreau JE, Bridle BW, Stephenson KB, Jenkins KM, Brunellière J, Bramson LJ et al. Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. Mol Ther 2009; 17: 1465–1472.

    Article  CAS  Google Scholar 

  27. Metharom P, Ellem KA, Schmidt C, Wei MQ . Lentiviral vector-mediate tyrosinase-related protein 2 gene transfer to dendritic cells for therapy of melanoma. Hum Gene Ther 2001; 12: 2203–2213.

    Article  CAS  Google Scholar 

  28. Osada T, Woo CY, McKinney M, Yang XY, Lei G, Labreche HG et al. Induction of Wilms tumor protein (WT1)-specificantitumor immunity using a truncated WT1-expressing adenovirus vaccine. Clin Cancer Res 2009; 15: 2789–2796.

    Article  CAS  Google Scholar 

  29. Du YC, Zhang J, Lu YR, Ning QZ, Wang Q . Fusion of CpG-ODN-stimulating dendritic cells with lewis lung cancer cells can enhance anti-tumor immune responses. Tissue Antigens 2006; 67: 368–376.

    Article  CAS  Google Scholar 

  30. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M . Inhibition of experimental tumor metastasis by alpha-galactosylceramide. J Immunol 1999; 163: 2387–2391.

    CAS  PubMed  Google Scholar 

  31. Kitajima M, Takaku H . Induction of antitumor acquired immunity by baculovirus autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin Vaccine Immunol 2008; 15: 376–378.

    Article  CAS  Google Scholar 

  32. Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007; 13: 902–911.

    Article  CAS  Google Scholar 

  33. Steitz J, Bruck J, Lenz J, Knop J, Tuting T . Depletion of CD25+CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8+ T-cell-dependent immune defense of B16 melanoma. Cancer Res 2001; 61: 8643–8646.

    CAS  PubMed  Google Scholar 

  34. Shibata S, Okano S, Yonemitsu Y, Onimura M, Sata S, Nagata-Takeshita H et al. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene. J Immunol 2006; 177: 3564–3576.

    Article  CAS  Google Scholar 

  35. Kaikkonen MU, Maatta AI, Ylä-Herttuala S, Airenne KJ . Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther 2010; 18: 987–992.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Y. Kato, K. Kondo and Y. Goto for excellent technical assistance. This work was supported in part by a grant from the Supporting Program for Creating University Ventures from the Japan Science and Technology Agency; a grant from the Research and Development Program for New Bio-industry Initiatives from the Ministry of Agriculture and Forestry and the Fisheries of Japan; a Grant-in-Aid for High Technology Research (No. 09309011) from the Ministry of Education, Science, Sports, and Culture, Japan; and by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor and Welfare, Japan.

Author information

Authors and Affiliations

  1. Department of Life and Environmental Sciences, Chiba Institute of Technology, Chiba, Japan

    Tomoyuki Suzuki & Hiroshi Takaku

  2. High Technology Research Center, Chiba Institute of Technology, Chiba, Japan

    Myint Oo Chang & Hiroshi Takaku

  3. Immunology Program, Benaroya Research Institute, Seattle, WA, USA

    Masayuki Kitajima

Authors
  1. Tomoyuki Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Myint Oo Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masayuki Kitajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Takaku
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Takaku.

Additional information

Note: Supplementary information is available on the Cellular & Molecular Immunology website.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, T., Oo Chang, M., Kitajima, M. et al. Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells. Cell Mol Immunol 7, 440–446 (2010). https://doi.org/10.1038/cmi.2010.48

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2010.48

Keywords

This article is cited by

Search

Advanced search

Quick links